The Latest Data on Lipid-Lowering Therapies for ASCVD and What it Means for Practicing Clinicians

The Latest Data on Lipid-Lowering Therapies f...

Up next

European Alzheimer's Care: A Live, Case-Based Forum on Amyloid-Targeting Therapy

How should our neurology clinics be fully prepared to integrate amyloid-targeting therapies (ATTs) into everyday, real-world practice? Credit available for this activity expires: 10/26/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/euro ...  Show more

Deciphering Clinical Data in Transthyretin Cardiac Amyloidosis for Today's Clinical Practice

Using real-world patient case examples, hear from expert faculty on how they would navigate treatment choices using the latest data for patients with ATTR-CM. Credit available for this activity expires: 10/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscap ...  Show more

Recommended Episodes

#361 Advanced Lipidology
The Curbsiders Internal Medicine Podcast

Lipids Update 2022: Cardiovascular Risk Reduction and New Medications on the Horizon with Erin Michos, MDShow description: Ready to take the next step in management of your patient with hyperlipidemia? Dr. Erin Michos (@erinmichos) returns to give us a lesson in Advanced Lipidolo ...  Show more

Recent Clinical Advances in Reducing Risk for Dyslipidemia
Medscape InDiscussion: Dyslipidemia

In this episode, host Dr. Laurence Sperling speaks with Drs Erin Michos and Peter Toth about optimal use of newer dyslipidemia therapies. Relevant disclosures can be found with the episode show notes on Medscape.com ( https://www.medscape.com/viewarticle/958749). The topics and di ...  Show more

Decoding Hyperlipidemia Management: What Does the Evidence Say? - Frankly Speaking Ep 332
Frankly Speaking About Family Medicine

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-332

Overview: In this episode, w ...

  Show more